Pharvaris N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports the results of the Annual General Meeting of Shareholders held by Pharvaris N.V. on June 26, 2026. The filing covers corporate governance actions and approvals related to the fiscal year ended December 31, 2025, and the upcoming fiscal year ending December 31, 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document confirms that shareholders adopted the Dutch statutory annual accounts for the fiscal year ended December 31, 2025, but does not disclose the numerical contents of those accounts.
Material Changes and Corporate Actions
- Auditor Appointment: Shareholders appointed PricewaterhouseCoopers Accountants N.V. as the external independent auditor for the fiscal year ending December 31, 2026.
- Director Discharge: Directors were discharged from liability regarding their performance of duties during the fiscal year ended December 31, 2025.
- Share Repurchase Authorization: Shareholders extended the Board's authorization to acquire shares and depository receipts in the Company's capital.
- Board Composition: Dr. Margareta Elisabeth Björk was re-appointed as a non-executive director.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a record of shareholder voting outcomes.
Key Facts for Investor Verification
- Verify the specific financial figures within the adopted Dutch statutory annual accounts for 2025, as they are not detailed in this filing.
- Confirm the terms and limits of the extended share repurchase authorization.
- Review the full audit report from PricewaterhouseCoopers Accountants N.V. for the 2025 fiscal year.